Download Library

INVESTORS & MEDIA

INVESTORS
& MEDIA

 
Download Library
Document Type
Dupilumab - Type 2 Biomarkers - Phase 3 Study LIBERTY ASTHMA QUEST
Dupilumab - Rapid and Sustained Improvements in FEV1 LIBERTY ASTHMA QUEST Study
Dupilumab - Dupilumab Produces Rapid and Sustained Improvements in Asthma-Related Symptoms - LIBERTY ASTHMA QUEST Study
View Presentation
View Presentation
View Presentation
2018 Proxy Statement
Proxy
2017 Annual Report
Annual Reports
= add file to Briefcase